Overview

Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the relative antiresorptive properties of 2 osteoporosis medications when combined with teriparatide.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Alendronate
Denosumab
Diphosphonates
Teriparatide